Brass Tax Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,225
Closed -$223K 249
2025
Q2
$223K Buy
+3,225
New +$219K 0.04% 211
2024
Q4
Sell
-1,700
Closed -$202K 212
2024
Q3
$202K Hold
1,700
0.04% 194
2024
Q2
$243K Hold
1,700
0.1% 116
2024
Q1
$218K Buy
+1,700
New +$202K 0.11% 105

Other funds holding NVO

Brass Tax Wealth Management's NVO Position: Q3 2025 in Review

Brass Tax Wealth Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,225 shares — an estimated $223K sold.

Brass Tax Wealth Management first reported a position in NVO in Q1 2024 and held it in 4 quarters. The position peaked at $243K in Q2 2024. 1,396 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Brass Tax Wealth Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Brass Tax Wealth Management sold 3,225 Novo Nordisk shares in Q3 2025, an estimated $223K.
  • Brass Tax Wealth Management first reported a position in Novo Nordisk in Q1 2024 and held it in 4 quarters.
  • Brass Tax Wealth Management's Novo Nordisk position peaked at $243K in Q2 2024.
  • 1,396 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Brass Tax Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.